Essilor: Publication of the 2015 Interim Financial Report

Regulatory News:

The Essilor International (Paris:EI) 2015 Interim Financial Report is being published today.

The report comprises the interim consolidated financial statements, the interim management report, the statement by the person responsible for the interim financial report and the auditors’ review report on the interim consolidated financial statements.

It can be downloaded from the Company’s website, www.essilor.com, in the "Investors / Publications & Downloads” section, or by clicking on:

http://www.essilor.com/en/Investors/Pages/PublicationsDownloads.aspx.

About Essilor

The world's leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its mission is to improve lives by improving sight. To support this mission, Essilor allocates more than €180 million to research and innovation every year, in a commitment to continuously bring new, more effective products to market. Its flagship brands are Varilux^®, Crizal^®, Transitions^®, Definity^®, Xperio^®, Optifog^®, Foster Grant^®, Bolon^TM and Costa^®. It also develops and markets equipment, instruments and services for eyecare professionals.

Essilor reported consolidated revenue of nearly €5.7 billion in 2014 and employs 58,000 people. It markets its products in more than 100 countries and has 33 plants, 490 prescription laboratories and edging facilities, as well as several research and development centers around the world. For more information, please visit www.essilor.com.

The Essilor share trades on the Euronext Paris market and is included in the Euro Stoxx 50 and CAC 40 indices.

Codes and symbols: ISIN: FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150729006665/en/